Stockscreener 앱 받기
22.33
1.27%
0.28
10 X Genomics Inc 주식(TXG)의 최신 뉴스
10x Genomics seen as key player in AI-driven biological data buildout - MSN
10x Genomics (TXG) Receives Upgrade to 'Outperform' by William B - GuruFocus
10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout10x Genomics (NASDAQ:TXG) - Benzinga
10x Genomics (NASDAQ:TXG) Shares Gap Up Following Analyst Upgrade - MarketBeat
10x Genomics (NASDAQ:TXG) Upgraded to Outperform at William Blair - MarketBeat
William Blair upgrades 10x Genomics (TXG) - MSN
Inside 10x Genomics’ Mission to Measure Biology at Scale - SynBioBeta
JPMorgan Chase & Co. Raises Position in 10x Genomics $TXG - MarketBeat
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know - Yahoo Finance
10X Genomics Stock Hits Day Low of $15.90 Amid Price Pressure - Markets Mojo
10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus
TXG Stock Price, Quote & Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
10x Genomics (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Bioptimus launches spatial biology atlas with 10x Genomics By Investing.com - Investing.com Canada
10x genomics CEO Saxonov sells $288,908 in stock By Investing.com - Investing.com Australia
10x genomics CEO Saxonov sells $288,908 in stock - Investing.com UK
10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares - MarketBeat
Serge Saxonov Sells 5,000 Shares of 10x Genomics (NASDAQ:TXG) Stock - MarketBeat
10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan
Vanguard realigns reporting; subsidiaries to report TXG holdings (TXG) - Stock Titan
Bioptimus launches spatial biology atlas with 10x Genomics - Investing.com
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs - The AI Journal
A new atlas aims to map 100,000 patient samples across 3 continents - Stock Titan
Vanguard amends 13G for 10X Genomics (NASDAQ: TXG) reporting 0 shares - Stock Titan
10x Genomics Undervalued Amid Consumables-Led Transition - National Today
10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG) - Seeking Alpha
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics - Investing.com
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics By Investing.com - Investing.com India
These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool
10x Genomics Stock Analysis: Recent Gains vs. Long-Term Growth Challenges | 2026News and Statistics - IndexBox
10X Genomics Hits Day High with 8.39% Surge Amid Market Volatility - Markets Mojo
ARK Investment Increases Stake in 10x Genomics (TXG) with Major Purchase - gurufocus.com
Cathie Wood’s ARK adds 10x Genomics stock, trims Arcturus - Investing.com
10x Genomics CRISPR Brain Atlas Collaboration And What It Means For Investors - Yahoo Finance
10x Genomics Inc Class A Trade Ideas — LSX:A2PPQJ - TradingView
10x Genomics Inc (TXG) Trading Down 10.96% on Mar 16 - GuruFocus
10x Genomics Shares Drop 10.9% Amid Market Volatility - National Today
10x Genomics Down Nearly 12%, on Pace for Largest Percent Decrease Since February 2025 -- Data Talk - Moomoo
10x Genomics (NASDAQ:TXG) Shares Down 10.9%Here's Why - MarketBeat
10x Genomics (TXG) Shares Drop Nearly 14% - GuruFocus
TXG SEC Filings10X Genomics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cathie Wood’s ARK trims 10X Genomics stock, adds DraftKings - Investing.com Nigeria
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells By Investing.com - Investing.com South Africa
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells - Investing.com
10X Genomics Experiences Evaluation Revision Amid Mixed Market Signals and Performance Metrics - Markets Mojo
10X Genomics Stock Hits Day Low of $18.80 Amid Price Pressure - Markets Mojo
Level Four Advisory Services LLC Acquires New Position in 10x Genomics $TXG - MarketBeat
Smart Money: Can 10x Genomics Inc grow without dilutionWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Risk Report: Can 10x Genomics Inc grow without dilutionJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn
10x Genomics $TXG Shares Bought by JPMorgan Chase & Co. - MarketBeat
1.27%
3.25%
자본화:
|
볼륨(24시간):